Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
Titel:
Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
Auteur:
Lal, Himal Poder, Airi Campora, Laura Geeraerts, Brecht Oostvogels, Lidia Vanden Abeele, Carline Heineman, Thomas C.